PHOENIX BIOTECH ACQUISITION CORP. Business Finance Contracts & Agreements
54 Contracts & Agreements
- Investor Rights Agreements (2 contracts)
- Note Agreements (5)
- Purchase Agreements (4)
- Registration Rights Agreements (10)
- Security Agreements (3)
- Share Agreements (2)
- Stock Agreements (9)
- Subscription Agreements (9)
- Underwriting Agreements (3)
- Waiver Agreements (2)
- Warrant Agreements (5)
- Registration Rights Agreement, by and between CERo Therapeutics Holdings, Inc., and an institutional investor, dated as of November 8, 2024 (Filed With SEC on November 12, 2024)
- Common Stock Purchase Agreement, by and between CERo Therapeutics Holdings, Inc., and an institutional investor, dated as of November 8, 2024 (Filed With SEC on November 12, 2024)
- Consent and Waiver Agreement, dated as of September 26, 2024, by and between CERo Therapeutics Holdings, Inc. and the investors party thereto (Filed With SEC on October 21, 2024)
- Registration Rights Agreement, dated as of September 26, 2024, by and between CERo Therapeutics Holdings, Inc. and the investors party thereto (Filed With SEC on October 21, 2024)
- Form of Consent and Waiver Agreement (Filed With SEC on September 25, 2024)
- Form of Registration Rights Agreement by and between CERo Therapeutics Holdings, Inc. and the investors named therein (Filed With SEC on September 25, 2024)
- Securities Purchase Agreement, dated as of September 25, 2024, by and between CERo Therapeutics Holdings, Inc. and the investors named therein (Filed With SEC on September 25, 2024)
- Form of Warrant (Filed With SEC on September 25, 2024)
- Registration Rights Agreement, dated as of March 29, 2024, by and between CERo Therapeutics Holdings, Inc. and the investors party thereto (Filed With SEC on April 2, 2024)
- Securities Purchase Agreement, dated as of March 29, 2024, by and between CERo Therapeutics Holdings, Inc. and the investors named therein (Filed With SEC on April 2, 2024)
- Purchase Agreement, dated as of February 23, 2024, by and between CERo Therapeutics Holdings, Inc. and Arena Business Solutions Global SPC II, Ltd on behalf of and for the account... (Filed With SEC on February 28, 2024)
- Form of Share Reallocation Agreement, dated as of February 14, 2024, by and among Phoenix Biotech Acquisition Corp., Phoenix Biotech Sponsor, LLC and the parties named therein (Filed With SEC on February 27, 2024)
- Registration Rights Agreement, dated as of February 14, 2024, by and between CERo Therapeutics Holdings, Inc. and the Lead Investor (Filed With SEC on February 27, 2024)
- Common Stock Purchase Agreement, dated as of February 14, 2024, by and between CERo Therapeutics Holdings, Inc. and the Lead Investor (Filed With SEC on February 27, 2024)
- Registration Rights Agreement, dated as of February 14, 2024, by and between Phoenix Biotech Acquisition Corp., CERo Therapeutics, Inc. and the investors named therein (Filed With SEC on February 27, 2024)
- Amended and Restated Securities Purchase Agreement, dated as of February 14, 2024, by and between Phoenix Biotech Acquisition Corp., CERo Therapeutics, Inc. and the investors... (Filed With SEC on February 27, 2024)
- Investor Rights and Lock-Up Agreement, dated February 14, 2024, by and between Phoenix Biotech Acquisition Corp. and the parties named therein (Filed With SEC on February 27, 2024)
- CERo Therapeutics Holdings, Inc. 2024 Employee Stock Purchase Plan (Filed With SEC on February 27, 2024)
- Form of Preferred Warrant (Filed With SEC on February 27, 2024)
- Form of Common Warrant (Filed With SEC on February 27, 2024)
- Form of Share Reallocation Agreement, dated as of February 14, 2024, by and among Phoenix Biotech Acquisition Corp., Phoenix Biotech Sponsor, LLC and the parties named therein (Filed With SEC on February 15, 2024)
- Registration Rights Agreement, dated as of February 14, 2024, by and between CERo Therapeutics Holdings, Inc. and Keystone Capital Partners, LLC (Filed With SEC on February 15, 2024)
- Registration Rights Agreement, dated as of February 14, 2024, by and between Phoenix Biotech Acquisition Corp., CERo Therapeutics, Inc. and the investors named therein (Filed With SEC on February 15, 2024)
- Investor Rights and Lock-Up Agreement, dated February 14, 2024, by and between Phoenix Biotech Acquisition Corp. and the parties named therein (Filed With SEC on February 15, 2024)
- First Amendment to Promissory Note dated December 6, 2023 made by and between Phoenix Biotech Acquisition Corp. and Phoenix Biotech Sponsor, LLC (Filed With SEC on December 11, 2023)
- Form of Convertible Note Purchase Agreement, by and among CERo Therapeutics, Inc. and the purchasers signatory thereto, dated June 6, 2023 (Filed With SEC on June 7, 2023)
- Amendment No. 1 to the Investment Management Trust Agreement, dated December 20, 2022, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on December 20, 2022)
- Promissory Note, dated December 20, 2022, issued to Phoenix Biotech Sponsor, LLC (Filed With SEC on December 20, 2022)
- Unit Subscription Agreement, dated October 5, 2021, between the Company and Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (Filed With SEC on October 12, 2021)
- Unit Subscription Agreement, dated October 5, 2021, between the Company and Cantor Fitzgerald & Co (Filed With SEC on October 12, 2021)
- Unit Subscription Agreement, dated October 5, 2021, between the Company and Phoenix Biotech Sponsor, LLC (Filed With SEC on October 12, 2021)
- Registration Rights Agreement, dated October 5, 2021, between the Company and certain security holders of the Company (Filed With SEC on October 12, 2021)
- Investment Management Trust Agreement, dated October 5, 2021, between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on October 12, 2021)
- Letter Agreement, dated October 5, 2021, by and among the Company and certain security holders, officers and directors of the Company (Filed With SEC on October 12, 2021)
- Warrant Agreement, dated October 5, 2021, between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on October 12, 2021)
- Underwriting Agreement, dated October 5, 2021, between the Company and Cantor Fitzgerald & Co (Filed With SEC on October 12, 2021)
- Form of Placement Unit Subscription Agreement between the Registrant and Cohen & Company Capital Markets (Filed With SEC on September 21, 2021)
- Form of Placement Unit Subscription Agreement between the Registrant and Cantor Fitzgerald & Co (Filed With SEC on September 21, 2021)
- Form of Letter Agreement by and between the Registrant, the Registrants security holders named therein, and the officers and directors of the Registrant (Filed With SEC on September 21, 2021)
- Form of Placement Unit Subscription Agreement with Phoenix Biotech Sponsor, LLC (Filed With SEC on September 21, 2021)
